Selected research
Industry Growth & Trends
Global Pharma Forecasting Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Pharma Forecasting Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharma Forecasting Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Pharma Forecasting Software market include IQVIA, JMP, SAS Institute, Oracle, Inpharmation, J+D Forecasting, ZS Associate, Cognizant and Kinaxis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Pharma Forecasting Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Pharma Forecasting Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharma Forecasting Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharma Forecasting Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Pharma Forecasting Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Pharma Forecasting Software Market by Company
IQVIA
JMP
SAS Institute
Oracle
Inpharmation
J+D Forecasting
ZS Associate
Cognizant
Kinaxis
Axtria
Symphony Health
Manthan
Model N
Sarjen
Koerber Pharma
WNS
SoftGroup
Nanjing Haiwei Pharmaceutical Technology
Pharma Forecasting Software Segment by Type
Stability Prediction
Formulation and Process Development
Other
Pharma Forecasting Software Segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Other
Pharma Forecasting Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Forecasting Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Forecasting Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Forecasting Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Pharma Forecasting Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Stability Prediction
- Formulation and Process Development
- Other
Applications
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Other
Companies covered
- IQVIA
- JMP
- SAS Institute
- Oracle
- Inpharmation
- J+D Forecasting
- ZS Associate
- Cognizant
- Kinaxis
- Axtria
- Symphony Health
- Manthan
- Model N
- Sarjen
- Koerber Pharma
- WNS
- SoftGroup
- Nanjing Haiwei Pharmaceutical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Pharma Forecasting Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Pharma Forecasting Software Market Size by Region (2021-2032)
- 1.4.1 Global Pharma Forecasting Software Market Size by Region (2021-2026)
- 1.4.2 Global Pharma Forecasting Software Market Size by Region (2027-2032)
- 1.5 Key Regions Pharma Forecasting Software Market Size (2021-2032)
- 1.5.1 North America Pharma Forecasting Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Pharma Forecasting Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Pharma Forecasting Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Pharma Forecasting Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Pharma Forecasting Software Market Size Growth Rate (2021-2032)
2 Pharma Forecasting Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Stability Prediction
- 2.1.2 Formulation and Process Development
- 2.1.3 Other
- 2.2 Global Pharma Forecasting Software Market Size by Type
- 2.2.1 Global Pharma Forecasting Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Pharma Forecasting Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Pharma Forecasting Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Pharma Forecasting Software Market Size by Regions
- 2.3.1 North America Pharma Forecasting Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Pharma Forecasting Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Pharma Forecasting Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Pharma Forecasting Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Pharma Forecasting Software Market Size Breakdown by Type (2021-2026)
3 Pharma Forecasting Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Contract Research Organizations (CROs)
- 3.1.3 Other
- 3.2 Global Pharma Forecasting Software Market Size by Application
- 3.2.1 Global Pharma Forecasting Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Pharma Forecasting Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Pharma Forecasting Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Pharma Forecasting Software Market Size by Regions
- 3.3.1 North America Pharma Forecasting Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Pharma Forecasting Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Pharma Forecasting Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Pharma Forecasting Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Pharma Forecasting Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Pharma Forecasting Software Industry Trends
- 4.2 Pharma Forecasting Software Industry Drivers
- 4.3 Pharma Forecasting Software Industry Opportunities and Challenges
- 4.4 Pharma Forecasting Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Pharma Forecasting Software Revenue (2021-2026)
- 5.2 Global Pharma Forecasting Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Pharma Forecasting Software Key Company Headquarters & Area Served
- 5.4 Global Pharma Forecasting Software Company, Product Type & Application
- 5.5 Global Pharma Forecasting Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Pharma Forecasting Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Pharma Forecasting Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Pharma Forecasting Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 IQVIA
- 6.1.1 IQVIA Company Information
- 6.1.2 IQVIA Business Overview
- 6.1.3 IQVIA Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 IQVIA Pharma Forecasting Software Product Portfolio
- 6.1.5 IQVIA Recent Developments
- 6.2 JMP
- 6.2.1 JMP Company Information
- 6.2.2 JMP Business Overview
- 6.2.3 JMP Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 JMP Pharma Forecasting Software Product Portfolio
- 6.2.5 JMP Recent Developments
- 6.3 SAS Institute
- 6.3.1 SAS Institute Company Information
- 6.3.2 SAS Institute Business Overview
- 6.3.3 SAS Institute Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 SAS Institute Pharma Forecasting Software Product Portfolio
- 6.3.5 SAS Institute Recent Developments
- 6.4 Oracle
- 6.4.1 Oracle Company Information
- 6.4.2 Oracle Business Overview
- 6.4.3 Oracle Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Oracle Pharma Forecasting Software Product Portfolio
- 6.4.5 Oracle Recent Developments
- 6.5 Inpharmation
- 6.5.1 Inpharmation Company Information
- 6.5.2 Inpharmation Business Overview
- 6.5.3 Inpharmation Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Inpharmation Pharma Forecasting Software Product Portfolio
- 6.5.5 Inpharmation Recent Developments
- 6.6 J+D Forecasting
- 6.6.1 J+D Forecasting Company Information
- 6.6.2 J+D Forecasting Business Overview
- 6.6.3 J+D Forecasting Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 J+D Forecasting Pharma Forecasting Software Product Portfolio
- 6.6.5 J+D Forecasting Recent Developments
- 6.7 ZS Associate
- 6.7.1 ZS Associate Company Information
- 6.7.2 ZS Associate Business Overview
- 6.7.3 ZS Associate Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ZS Associate Pharma Forecasting Software Product Portfolio
- 6.7.5 ZS Associate Recent Developments
- 6.8 Cognizant
- 6.8.1 Cognizant Company Information
- 6.8.2 Cognizant Business Overview
- 6.8.3 Cognizant Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Cognizant Pharma Forecasting Software Product Portfolio
- 6.8.5 Cognizant Recent Developments
- 6.9 Kinaxis
- 6.9.1 Kinaxis Company Information
- 6.9.2 Kinaxis Business Overview
- 6.9.3 Kinaxis Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Kinaxis Pharma Forecasting Software Product Portfolio
- 6.9.5 Kinaxis Recent Developments
- 6.10 Axtria
- 6.10.1 Axtria Company Information
- 6.10.2 Axtria Business Overview
- 6.10.3 Axtria Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Axtria Pharma Forecasting Software Product Portfolio
- 6.10.5 Axtria Recent Developments
- 6.11 Symphony Health
- 6.11.1 Symphony Health Company Information
- 6.11.2 Symphony Health Business Overview
- 6.11.3 Symphony Health Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Symphony Health Pharma Forecasting Software Product Portfolio
- 6.11.5 Symphony Health Recent Developments
- 6.12 Manthan
- 6.12.1 Manthan Company Information
- 6.12.2 Manthan Business Overview
- 6.12.3 Manthan Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Manthan Pharma Forecasting Software Product Portfolio
- 6.12.5 Manthan Recent Developments
- 6.13 Model N
- 6.13.1 Model N Company Information
- 6.13.2 Model N Business Overview
- 6.13.3 Model N Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Model N Pharma Forecasting Software Product Portfolio
- 6.13.5 Model N Recent Developments
- 6.14 Sarjen
- 6.14.1 Sarjen Company Information
- 6.14.2 Sarjen Business Overview
- 6.14.3 Sarjen Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Sarjen Pharma Forecasting Software Product Portfolio
- 6.14.5 Sarjen Recent Developments
- 6.15 Koerber Pharma
- 6.15.1 Koerber Pharma Company Information
- 6.15.2 Koerber Pharma Business Overview
- 6.15.3 Koerber Pharma Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Koerber Pharma Pharma Forecasting Software Product Portfolio
- 6.15.5 Koerber Pharma Recent Developments
- 6.16 WNS
- 6.16.1 WNS Company Information
- 6.16.2 WNS Business Overview
- 6.16.3 WNS Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 WNS Pharma Forecasting Software Product Portfolio
- 6.16.5 WNS Recent Developments
- 6.17 SoftGroup
- 6.17.1 SoftGroup Company Information
- 6.17.2 SoftGroup Business Overview
- 6.17.3 SoftGroup Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 SoftGroup Pharma Forecasting Software Product Portfolio
- 6.17.5 SoftGroup Recent Developments
- 6.18 Nanjing Haiwei Pharmaceutical Technology
- 6.18.1 Nanjing Haiwei Pharmaceutical Technology Company Information
- 6.18.2 Nanjing Haiwei Pharmaceutical Technology Business Overview
- 6.18.3 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Nanjing Haiwei Pharmaceutical Technology Pharma Forecasting Software Product Portfolio
- 6.18.5 Nanjing Haiwei Pharmaceutical Technology Recent Developments
7 North America
- 7.1 North America Pharma Forecasting Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Pharma Forecasting Software Market Size by Country (2021-2026)
- 7.3 North America Pharma Forecasting Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Pharma Forecasting Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Pharma Forecasting Software Market Size by Country (2021-2026)
- 8.3 Europe Pharma Forecasting Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pharma Forecasting Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Pharma Forecasting Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Pharma Forecasting Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Pharma Forecasting Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Pharma Forecasting Software Market Size by Country (2021-2026)
- 10.3 South America Pharma Forecasting Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pharma Forecasting Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Pharma Forecasting Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Pharma Forecasting Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst